More radiation may decrease breast cancer recurrence risk in some patients
the ONA take:
After conservation surgery, some women who undergo additional radiation given to the lymph nodes along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence, according to a study in the New England Journal of Medicine.
Researchers led by Tim Whelan, MD, of McMaster University’s Michael G. DeGroote School of Medicine looked at women with axillary node-positive or high-risk node-negative breast cancer in order to determine whether adding regional node irradiation to whole-breast irradiation proved more beneficial than whole-breast irradiation alone.
More than 1,800 patients were included in the 14-year study as part of NCIC Clinical Trials Group at Queen’s University in Ontario.
They found that additional radiation to the surrounding lymph nodes reduced risk of subsequence recurrence both locally and at sites distant from the breast.
“This study is important because it shows that additional radiation to the surrounding lymph nodes provides added benefit to women, particularly those with involvement of the lymph nodes in the axilla,” Dr. Whelan said. “Further research is necessary to determine which women are most likely to benefit and who may avoid the additional radiation.”
Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|